KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Sales: 2009-2024

Historic Return on Sales for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -0.14%.

  • Pacira BioSciences' Return on Sales rose 16.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 16.00%. This contributed to the annual value of -0.14% for FY2024, which is 20.00% down from last year.
  • As of FY2024, Pacira BioSciences' Return on Sales stood at -0.14%, which was down 328.50% from 0.06% recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Return on Sales ranged from a high of 0.34% in FY2020 and a low of -0.14% during FY2024.
  • Its 3-year average for Return on Sales is -0.02%, with a median of 0.02% in 2022.
  • In the last 5 years, Pacira BioSciences' Return on Sales skyrocketed by 36bps in 2020 and then declined by 26bps in 2021.
  • Over the past 5 years, Pacira BioSciences' Return on Sales (Yearly) stood at 0.34% in 2020, then declined by 26bps to 0.08% in 2021, then decreased by 5bps to 0.02% in 2022, then climbed by 4bps to 0.06% in 2023, then fell by 20bps to -0.14% in 2024.